Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

(2022) Patrick M. Forde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer

(2021) David Boyce-Fappiano et al.   Clinical Lung Cancer

Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer

(2021) Jin-Yu Sun et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

(2021) Enriqueta Felip et al.   LANCET

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy

(2021) Zhouguang Hui et al.   JAMA Oncology

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial

(2021) Cecile Le Pechoux et al.   LANCET ONCOLOGY

Younger patients operated for lung cancer have a better prognosis

(2020) Tomasz Marjanski et al.   Journal of Thoracic Disease

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

(2020) Yi-Long Wu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

(2019) Jeffrey D. Bradley et al.   JOURNAL OF CLINICAL ONCOLOGY

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

(2018) Zhongxing Liao et al.   JOURNAL OF CLINICAL ONCOLOGY

An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy

(2018) Li Ma et al.   Radiation Oncology

The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices

(2017) Ching-Chieh Yang et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non–Small-Cell Lung Cancer

(2017) Robert T. Dess et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial

(2017) Stephen G. Chun et al.   JOURNAL OF CLINICAL ONCOLOGY

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

(2017) Scott J. Antonia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non–Small-Cell Lung Cancer

(2015) Elyn H. Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer

(2013) Gregory T. Armstrong et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of smoking on mortality of patients with non-small cell lung cancer

(2013) Seung Jun Lee et al.   Thoracic Cancer

Local recurrence after surgery for early stage lung cancer

(2009) Chris R. Kelsey et al.   CANCER